- Report
- October 2024
- 200 Pages
Global
From €4529EUR$4,949USD£3,935GBP
- Report
- October 2024
- 186 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- February 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- April 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- February 2025
- 291 Pages
Global
From €3294EUR$3,600USD£2,862GBP
- Report
- February 2023
- 178 Pages
Global
From €5398EUR$5,899USD£4,690GBP
- Report
- October 2023
- 187 Pages
Global
From €2059EUR$2,250USD£1,789GBP
€4118EUR$4,500USD£3,578GBP
- Book
- June 2023
- 352 Pages
Quantum Computing in Drug Discovery is a rapidly growing field of computing that uses quantum computing to accelerate the process of drug discovery. It is based on the principles of quantum mechanics, which allow for the manipulation of data at the atomic and subatomic level. This technology has the potential to revolutionize the drug discovery process by providing unprecedented speed and accuracy.
Quantum Computing in Drug Discovery is used to analyze large datasets, identify patterns, and develop new drugs. It can also be used to simulate the behavior of molecules, allowing researchers to better understand the effects of drugs on the body. Additionally, quantum computing can be used to optimize drug delivery systems, making them more efficient and cost-effective.
Companies in the Quantum Computing in Drug Discovery market include IBM, Microsoft, Google, D-Wave Systems, Rigetti Computing, and 1QBit. Show Less Read more